SCYX CIK: 1178253

SCYNEXIS, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
109
FY22:
79.1
FY23:
102
FY24:
72.2
FY25:
40.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
10.5
FY22:
8.75
FY23:
26.3
FY24:
18.5
FY25:
18.7
Total assets
Change from FY21 to FY25
millions USD
FY21:
120
FY22:
87.8
FY23:
128
FY24:
90.6
FY25:
59.0

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
13.6
FY22:
17.6
FY23:
16.3
FY24:
24.1
FY25:
5.73
(negative)
Change from FY21 to FY25
millions USD
FY21:
65.0
FY22:
67.0
FY23:
39.1
FY24:
11.5
FY25:
3.92
(positive)
Change from FY21 to FY25
millions USD
FY21:
41.3
FY22:
3.23
FY23:
73.0
FY24:
55.1
FY25:
49.4
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
120
FY22:
87.8
FY23:
128
FY24:
90.6
FY25:
59.0

All amounts in millions USD Data source:SEC EDGAR